Replies to post #43285 on Biotech Values

[DewDiligence]

>So basically do you think that all plasma-derived therapeutics like OMRI has will be replaced in the future by synthetic, genetic-engineered therapeutics?<

Yes, eventually, provided that production cost for the recombinants is low enough.

>That is my view but it might take a few years.<

#msg-17114738 :-)